http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5597901-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_966a6c1f382ec9bcb5e3839dfd73e5b8
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y10S930-141
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y10S435-948
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y10S530-828
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-55
classificationIPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12R1-91
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12P21-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K1-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K1-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-005
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-52
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-55
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-54
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-195
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P37-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00
filingDate 1995-05-25-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 1997-01-28-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b29fb884e2c8c900c5012efb789b508c
publicationDate 1997-01-28-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber US-5597901-A
titleOfInvention Homogeneous human interleukin 2
abstract Human interleukin 2 (IL-2) derived from induced human malignant cells has been purified to homogeneity using multiple high performance liquid chromatography (HPLC) steps. The purified IL-2 exhibits potent activity promoting the long-term in vitro culture of antigen-specific effector T-lymphocytes and in modulating lymphocyte reactivity.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7825246-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7081354-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2011212077-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2005245524-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2006292203-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9332999-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2007259904-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2005282814-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2003036170-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7456176-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5795769-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9332998-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5795777-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7208493-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6737522-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2009275582-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8138199-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2009275569-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9808266-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8133900-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8481536-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2007259876-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8372971-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2004167198-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7528143-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10391094-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7691858-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2007208019-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8604042-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2009286789-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2010278811-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6190901-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2010330030-A1
priorityDate 1982-09-16-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4925919-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4778879-A
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23619366
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226410615
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5789
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID85318
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127686754
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID18633279
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID499950
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395500
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127614329
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1134
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID19649
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID37927
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226394880
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129922365
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129894804
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226409524
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226651667
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID62474
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226409525
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226400252
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23830
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226400253
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127550382
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1133
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128721138
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226423128

Total number of triples: 91.